22 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
28 Jun 22
Departure of Directors or Certain Officers
9:46am
and reimbursement of three innovative cancer drugs – Blincyto®, Jevtana® and Votrient® – in the U.S., EU and MENA regions, with a focus on global medical
8-K
EX-99.1
1wztyk
9 Jun 21
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
9:06am
10-KT
ixwujtyv kbprmuggl
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
ubykc pq8
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
xvi thb88sjifj
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
10-K
l6r8hskdvbhy
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
ufqebf 3on
6 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
uz7 do25sv8
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
cggu88gflh yi
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
e1d5u
22 Oct 13
Registration of securities (amended)
12:00am